Try our Advanced Search for more refined results
AstraZeneca UK Limited et al. v. Joshua Atchley et al.
Case Number:
23-9
Court:
Nature of Suit:
Firms
Companies
Sectors & Industries:
-
June 24, 2024
Justices Undo Terror Victims' Win, Citing Twitter Decision
The U.S. Supreme Court on Monday swept aside a D.C. Circuit ruling that threatened to expose major pharmaceutical companies to liability for terrorist attacks that injured or killed hundreds of U.S. soldiers and civilians in Iraq.
-
June 04, 2024
Pharma Cos. Tell Justices Feds Support Remanding Terror Suit
Pharmaceutical companies urged the U.S. Supreme Court on Tuesday to heed the federal government's suggestion to throw out a D.C. Circuit ruling holding them potentially liable for allegedly financing terror attacks against U.S. servicemembers through contracts with the Iraqi government.
-
January 01, 2024
Appellate Outlook: Circuit Splits & Hot Topics To Track In 2024
The 2024 appellate almanac is looking lively after eye-popping opinions and arguments in 2023's homestretch. As the new year begins, several circuit splits seem more serious, ideological imbalances are in the spotlight, and luminaries of the U.S. Supreme Court bar are locked in a burgeoning battle over alleged corporate complicity in terrorism.
-
October 02, 2023
High Court Seeks SG Opinion In Pharma Terror-Funding Suit
The U.S. Supreme Court on Monday asked the solicitor general to weigh in on a case that considers whether several pharmaceutical giants could be held liable for allegedly financing terror attacks against U.S. service members by maintaining medical supply contracts with the Iraqi government.
-
August 04, 2023
US Chamber Says Big Pharma Can't Be Blamed For Terrorism
The U.S. Chamber of Commerce on Friday asked the U.S. Supreme Court to overturn a lower court's ruling that found pharmaceutical companies can be sued for attacks on U.S. soldiers, citing the high court's recent decision absolving the company formerly known as Twitter of Anti-Terrorism Act claims.
-
July 06, 2023
Pharma Cos. Urge High Court To Toss Terror-Funding Ruling
A group of pharmaceutical companies have asked the U.S. Supreme Court to vacate a District of Columbia Circuit Court ruling that found them liable for attacks that injured or killed U.S. soldiers, saying medical goods sales in Iraq didn't amount to funding terrorism.